Trial Profile
Phase II study of antineoplastons A10 and AS2-1 in patients with stage II, III, or IV mantle cell lymphoma
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 02 Sep 2005 New trial record.